Search results for

NPR's Leila Fadel speaks to Tareq Baconi, a Palestinian scholar. His memoir, "Fire in Every Direction," explores queer identity, family history, and political awakening.

The Trump administration says it will use a $4.5 billion in contingency funds to cover partial SNAP payments for November, but it might take weeks or months for some recipients to get their money.

President Trump wants to expand grazing and reduce regulations to grow the American cattle herd. But his plan to import Argentinian beef to lower prices is causing a backlash across the heartland.

A team of academics studying satellites accidentally intercepted phone calls, texts and other sensitive communications. They were able to intercept the data with just a satellite dish on the roof.

For decades, Tibetans built a capital-in-exile in Dharamshala in India, and they sent their kids to a school founded by the Dalai Lama. But their numbers are now decreasing.

There are several big races to watch this Election Day. New York City will elect a mayor, New Jersey and Virginia will pick a governor and California will decide a consequential redistricting ballot.

Do Democrats have an advantage going into Tuesday's elections? NPR's Steve Inskeep asks Faiz Shakir, chief political adviser to Sen. Bernie Sanders, I-Vt.

The comments came as federal courts ordered the Trump administration to resume food assistance payments.

NPR's Michel Martin speaks with Michael Cannon, director of health policy studies at the Cato Institute, about why he believes the ACA has failed and how affordable healthcare could be achieved.

A worsening famine has spread to two regions in Sudan, as a paramilitary group accused of past genocide now controls El Fasher, leaving 200,00 civilians trapped and fearing mass killings.

Tuberculosis is the world's deadliest infectious disease, but detecting it in remote and war-torn regions can be difficult. That's why some health clinics are now using AI to screen for the illness.

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?